These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34505042)

  • 1. Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake.
    Beaulieu MC; Boivin-Proulx LA; Matteau A; Mansour S; Gobeil JF; Potter BJ
    CJC Open; 2021 Aug; 3(8):1025-1032. PubMed ID: 34505042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
    Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
    Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registry.
    Potter BJ; Andò G; Cimmino G; Ladeiras-Lopes R; Frikah Z; Chen XY; Virga V; Goncalves-Almeida J; Camm AJ; Fox KAA
    Clin Cardiol; 2018 Apr; 41(4):470-475. PubMed ID: 29663443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Boivin-Proulx LA; Potter BJ; Dorais M; Perreault S
    CJC Open; 2023 Jan; 5(1):15-23. PubMed ID: 36700177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
    Mennuni MG; Halperin JL; Bansilal S; Schoos MM; Theodoropoulos KN; Meelu OA; Sartori S; Giacoppo D; Bernelli C; Moreno PR; Krishnan P; Baber U; Lucarelli C; Dangas GD; Sharma SK; Kini AS; Tamburino C; Chieffo A; Colombo A; Presbitero P; Mehran R
    Am J Cardiol; 2015 Jul; 116(1):37-42. PubMed ID: 25956624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Benetou DR; Varlamos C; Ktenas D; Tsiafoutis I; Koutouzis M; Bampali T; Mantis C; Zarifis J; Skalidis E; Aravantinos D; Varvarousis D; Lianos I; Kanakakis J; Pisimisis E; Ziakas A; Davlouros P; Alexopoulos D;
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):11-20. PubMed ID: 33034806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Angiolillo DJ; Bhatt DL; Cannon CP; Eikelboom JW; Gibson CM; Goodman SG; Granger CB; Holmes DR; Lopes RD; Mehran R; Moliterno DJ; Price MJ; Saw J; Tanguay JF; Faxon DP
    Circulation; 2021 Feb; 143(6):583-596. PubMed ID: 33555916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.
    De Luca L; Di Lenarda A; Rubboli A; Bolognese L; Gonzini L; Fortuni F; Navazio A; Poletti F; Ledda A; Urbinati S; Gabrielli D; Gulizia MM;
    Eur J Intern Med; 2021 Jun; 88():28-34. PubMed ID: 33838988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study.
    Otsuki H; Yamaguchi J; Kamishima K; Arashi H; Hagiwara N
    Heart Vessels; 2018 Sep; 33(9):986-996. PubMed ID: 29549436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen.
    Kawakami S; Yasuda S; Ogawa H
    J Cardiol; 2020 Jul; 76(1):35-43. PubMed ID: 32389534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan.
    Nakano Y; Matoba T; Yamamoto M; Katsuki S; Koga Y; Mukai Y; Inoue S; Suematsu N; Higo T; Takemoto M; Miyata K; Usui M; Kadokami T; Tashiro H; Morishige K; Hironaga K; Tsutsui H;
    Circ Rep; 2023 Jul; 5(7):282-288. PubMed ID: 37435100
    [No Abstract]   [Full Text] [Related]  

  • 16. Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials.
    Potpara TS; Mujovic N; Proietti M; Dagres N; Hindricks G; Collet JP; Valgimigli M; Heidbuchel H; Lip GYH
    Europace; 2020 Jan; 22(1):33-46. PubMed ID: 31603196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
    Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
    Chandrasekhar J; Mastoris I; Baber U; Sartori S; Schoos M; Bansilal S; Dangas G; Mehran R
    Am Heart J; 2015 Dec; 170(6):1234-42. PubMed ID: 26678646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study.
    Heger LA; Danzer M; Bode C; Hortmann M; Duerschmied D; Olivier CB; Moser M
    Front Med (Lausanne); 2020; 7():414. PubMed ID: 33117822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.